title: Analysis of synaptic growth and function in Drosophila with an extended larval stage.
abstract: The Drosophila larval neuromuscular junction (NMJ) is a powerful system for the genetic and molecular analysis of neuronal excitability, synaptic transmission, and synaptic development. However, its use for studying age-dependent processes, such as maintenance of neuronal viability and synaptic stability, are temporally limited by the onset of pupariation and metamorphosis. Here we characterize larval NMJ growth, growth regulation, structure, and function in a developmental variant with an extended third instar (ETI). RNAi-knockdown of the prothoracicotropic hormone receptor, torso, in the ring gland of developing larvae leaves the timing of first and second instar molts largely unchanged, but triples duration of the third instar from 3 to 9.5 d (McBrayer et al., 2007; Rewitz et al., 2009). During this ETI period, NMJs undergo additional growth (adding >50 boutons/NMJ), and this growth remains under the control of the canonical regulators Highwire and the TGFβ/BMP pathway. NMJ growth during the ETI period occurs via addition of new branches, satellite boutons, and interstitial boutons, and continues even after muscle growth levels off. Throughout the ETI, organization of synapses and active zones remains normal, and synaptic transmission is unchanged. These results establish the ETI larval system as a viable model for studying motor neuron diseases and for investigating time-dependent effects of perturbations that impair mechanisms of neuroprotection, synaptic maintenance, and response to neural injury.
authors.affiliation: Laboratory of Genetics and Institute on Aging, University of Wisconsin, Madison, Wisconsin 53706, USA.
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Miller
authors.forename: Shannon L
authors.initials: SL
authors.lastname: Ballard
authors.forename: Barry
authors.initials: B
authors.lastname: Ganetzky
mesh_terms: D000818:Animals; D029721:Drosophila Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology; D004331:Drosophila melanogaster / Q000254:growth & development* / Q000502:physiology; D007301:Insect Hormones / Q000502:physiology; D019476:Insect Proteins / Q000037:antagonists & inhibitors / Q000235:genetics; D007814:Larva; D006899:Mixed Function Oxygenases / Q000235:genetics / Q000502:physiology; D018978:Molting / Q000502:physiology; D009420:Nervous System / Q000254:growth & development*; D009469:Neuromuscular Junction / Q000254:growth & development*; D017729:Presynaptic Terminals / Q000502:physiology* / Q000648:ultrastructure; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000494:pharmacology; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D011987:Receptors, Steroid / Q000037:antagonists & inhibitors / Q000235:genetics; D013997:Time Factors
chemical_list: D029721:Drosophila Proteins; D007301:Insect Hormones; D019476:Insect Proteins; D034741:RNA, Small Interfering; D011987:Receptors, Steroid; C055469:ecdysone receptor; C467903:ecdysone receptor A, insect; C009089:prothoracicotropic hormone; D006899:Mixed Function Oxygenases; C496261:Phm protein, Drosophila; D020794:Receptor Protein-Tyrosine Kinases; C080148:tor protein, Drosophila